Eight Finalist Teams Eye P&T Competition

The 19th Annual National Student Pharmacist Pharmacy & Therapeutics (P&T) Competition once again will be a highlight of student pharmacist programming at the AMCP Annual Meeting, March 25-28 in San Diego, California. This year 67 Schools and Colleges of Pharmacy registered for the competition. The Foundation knows that every entry represents a considerable amount of work and is a laudable accomplishment! Eight finalist teams will compete in San Diego on March 26 for the prestigious prize. They are:  

Lipscomb University

Rutgers University

University of California at San Francisco

University of Colorado

University of Minnesota

University of Southern California

University of Washington

University of Wisconsin—Madison    

 

Competition Day Schedule  

Tuesday, March 26  |  Convention Center Room 2 

 

Time  Event
8:00 am Presentation: University of California, San Francisco 
9:00 am Presentation: Lipscomb University College of Pharmacy 
10:00 am Break 
10:15 am Presentation: University of Washington 
11:15 am  Presentation: Univ. of Wisconsin—Madison School of Pharmacy
12:15 pm  Lunch 
1:15 pm Presentation: Rutgers Ernest Mario School of Pharmacy   
2:15 pm Presentation: University of Southern California
3:15 pm Break 
3:30 pm  Presentation: University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences
4:30 pm  Presentation: University of Minnesota College of Pharmacy 

 

We also extend our congratulations to the following 2019 Honorable Mention Semi-Finalist teams:  

California Northstate College of Pharmacy

The Ohio State University

University of California at San Diego

University of Houston

University of Michigan

University of Missouri—Kansas City

University of North Carolina at Chapel Hill

University of the Pacific

University of Utah

Western University of Health Sciences

 

P&T Winners

 

The study drug for the P&T Competition is TYMLOS® (abaloparatide) injection. Tymlos is indicated for the treatment of postmenopausal women with osteoporosis at high risk for fracture defined as a history of osteoporotic fracture, multiple risk factors for fracture, or patients who have failed or are intolerant to other available osteoporosis therapy. The Foundation would like to thank Radius Health, Inc., for use of its dossier for Tymlos. We are also grateful to our partners Genentech, Amgen, Supernus, and Dymaxium/AMCP eDossier. Learn more about the P&T Competition.

NOTE: Participating in the P&T Competition goes a long way for students pharmacists to receive an AMCP graduation cord. Winners automatically receive the cord, and participants need only achieve one other AMCP or AMCP Foundation distinction to receive the honor.
 

(image: winners of the 2018 P&T Competition; University of North Carolina at Chapel Hill Eshelman School of Pharmacy.)